- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01731210
Clinical Evaluation Of The Nano Lv Lead System In Chronic Situation (LENEA) (LENEA)
March 12, 2018 updated by: LivaNova
Clinical Evaluation Of The Nano Lv Lead System In Chronic Situation
The LENEA study is an international, prospective, open label, non-randomized multicenter clinical research study designed to assess the safety and effectiveness of the NANO LV lead system.
Study Overview
Status
Terminated
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
9
Phase
- Phase 2
- Phase 3
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Rouen, France, 76000
- CHU Charles Nicolle
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Approved indication per ACC/AHA/HRS guidelines for implantation of a CRT-D system for treatment of heart failure or life threatening ventricular tachyarrhythmia(s)
- Receiving a new implant OR undergoing an upgrade from an existing ICD or pacemaker implant with no prior implanted LV lead OR undergoing a new LV implant attempt consecutive to a recent LV lead placement failure not related to coronary sinus cannulation failure
- Patient receiving the PARADYM RF CRT or PARADYM RF CRT SONR devices
- Ability to provide informed consent for study participation and is willing and able to comply with the prescribed follow-up tests and schedule of evaluations
Exclusion Criteria:
- Ventricular tachyarrhythmia of transient or reversible causes such as acute myocardial infarction, digitalis intoxication, drowning, electrocution, electrolyte imbalance, hypoxia or sepsis, uncorrected at the time of the enrolment;
- Incessant Ventricular tachyarrhythmias;
- Unstable angina, or acute MI , CABG , or PTCA within the past 4 weeks;
- Correctable valvular disease that is the primary cause of heart failure;
- Post heart transplant (patients who are waiting for a heart transplant are allowed in the study);
- Patient who had previously a permanently implanted LV lead;
- Concurrent implant with another pacemaker or ICD (previously implanted pacemaker or ICD devices should be removed prior to implant with the Paradym RF CRT-D or Paradym RF CRT SONR);
- Already included in another clinical study that could confound the results of this study;
- Life expectancy less than 1 year.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Freedom from left ventricular lead related complications through 1 month
Time Frame: 1 month
|
1 month
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
October 31, 2012
Study Completion (Actual)
December 19, 2013
Study Registration Dates
First Submitted
November 15, 2012
First Submitted That Met QC Criteria
November 15, 2012
First Posted (Estimate)
November 21, 2012
Study Record Updates
Last Update Posted (Actual)
March 13, 2018
Last Update Submitted That Met QC Criteria
March 12, 2018
Last Verified
March 1, 2018
More Information
Terms related to this study
Other Study ID Numbers
- LCNA02 - LENEA
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on LV Lead
-
National Institute of Environmental Health Sciences...Completed
-
Deutsches Herzzentrum MuenchenUnknownPacemaker Electrode Lead DisplacementGermany
-
Glock Health, Science and Research GmbHCompleted
-
Cornell UniversityThrasher Research FundCompleted
-
Nelson Marlborough Institute of TechnologyMayo ClinicUnknownLead | Toxicology
-
Oregon Health and Science UniversityRecruiting
-
Danish Study GroupNot yet recruitingLV Dysfunction | IHDDenmark
-
Medical University of South CarolinaEnrolling by invitation
-
Novozymes A/SUniversidad Iberoamericana A.C., Mexico; Linus Biotechnology IncCompletedEffect of Lactobacillus Plantarum DSM 33464 on Blood Lead Levels in Young Women of Child-bearing AgeElevated Blood Lead LevelsMexico
-
Assiut UniversityUnknownPacemaker Lead DysfunctionItaly
Clinical Trials on implantation of the new LV lead: NANO system.
-
Ann Marie ChikowskiMain Line HealthCompletedDilated Cardiomyopathy | Congestive Heart Failure | Ischemic Congestive CardiomyopathyUnited States
-
Rigshospitalet, DenmarkCompletedLeft Bundle-Branch Block | Heart Failure With Reduced Ejection FractionDenmark
-
Abbott Medical DevicesCompleted
-
MicroPort CRMActive, not recruitingHeart Failure | Cardiac Resynchronization TherapyNetherlands, France, Germany, Spain, Italy, Austria, Portugal
-
Abbott Medical DevicesActive, not recruitingHeart Failure | Heart Block | Bradycardia | Syncope | Cardiomyopathies | Sinus Node DysfunctionUnited States, Singapore, France, India, Italy
-
Royal Brompton & Harefield NHS Foundation TrustUnknownHeart FailureUnited Kingdom
-
Tomsk National Research Medical Center of the Russian...Not yet recruitingHeart Failure | Left Bundle-Branch Block | Ischemic Cardiomyopathy | Left Ventricular Dysfunction | Non-ischemic Dilated Cardiomyopathy | Left Ventricle RemodelingRussian Federation
-
Josep Lluis Mont GirbauInstitut d'Investigacions Biomèdiques August Pi i Sunyer; Centro de Investigación...CompletedPhysiological Pacing | Resynchronization TherapySpain
-
Medacta International SARecruiting